Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suprimun safety and efficacy in first kidney transplant recipients
IRCT2013012612274N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of Suprimun in kidney allograft rejection (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Started Sep 2012; status: completed.
02
Drugs
Suprimun
03
Conditions
kidney allograft rejection
Beyond the preview
Go deeper on IRCT2013012612274N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2013012612274N1.